Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge is advising Acrinova in its rights issue
Mandate

Vinge is advising Acrinova in its rights issue

May 07, 2021 Capital Markets and Public M&A

Vinge is advising Acrinova AB (publ) in connection with a rights issue which will provide Acrinova with issue proceeds amounting to a maximum of SEK 130 million.

Acrinova is an entrepreneurial-run real estate company operating in southern Sweden with a focus on the Öresund region. Acrinova’s property portfolio is developed through acquisitions, project development and refinement.

Acrinova is listed on Nasdaq First North Growth Market.

Vinge’s team consisted of Linnéa Sellström, Julia Hirschberg and Lorin Arabi.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

 HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

 Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

 Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026